These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15561839)

  • 1. Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers.
    Gattringer R; Urbauer E; Traunmüller F; Zeitlinger M; Dehghanyar P; Zeleny P; Graninger W; Müller M; Joukhadar C
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4650-3. PubMed ID: 15561839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of telithromycin in peripheral soft tissues.
    Traunmüller F; Fille M; Thallinger C; Joukhadar C
    Int J Antimicrob Agents; 2009 Jul; 34(1):72-5. PubMed ID: 19380214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of telithromycin into the nasal mucosa and ethmoid bone of patients undergoing rhinosurgery for chronic sinusitis.
    Kuehnel TS; Schurr C; Lotter K; Kees F
    J Antimicrob Chemother; 2005 Apr; 55(4):591-4. PubMed ID: 15761076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis.
    Traunmüller F; Zeitlinger M; Zeleny P; Müller M; Joukhadar C
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3185-9. PubMed ID: 17606673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.
    Zeitlinger M; Wagner CC; Heinisch B
    Clin Pharmacokinet; 2009; 48(1):23-38. PubMed ID: 19071882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
    Burkhardt O; Brunner M; Schmidt S; Grant M; Tang Y; Derendorf H
    J Antimicrob Chemother; 2006 Sep; 58(3):632-6. PubMed ID: 16840426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.
    Namour F; Wessels DH; Pascual MH; Reynolds D; Sultan E; Lenfant B
    Antimicrob Agents Chemother; 2001 Jan; 45(1):170-5. PubMed ID: 11120961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and absolute oral bioavailability of an 800-mg oral dose of telithromycin in healthy young and elderly volunteers.
    Perret C; Lenfant B; Weinling E; Wessels DH; Scholtz HE; Montay G; Sultan E
    Chemotherapy; 2002 Dec; 48(5):217-23. PubMed ID: 12476037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
    Conte JE; Golden JA; Kipps J; Zurlinden E
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3508-15. PubMed ID: 15328118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.
    Islinger F; Bouw R; Stahl M; Lackner E; Zeleny P; Brunner M; Müller M; Eichler HG; Joukhadar C
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4246-9. PubMed ID: 15504848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of telithromycin in human plasma and microdialysates by high-performance liquid chromatography.
    Traunmüller F; Gattringer R; Zeitlinger MA; Graninger W; Müller M; Joukhadar C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):133-6. PubMed ID: 15990374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Pulm Pharmacol Ther; 2007; 20(5):549-55. PubMed ID: 17127087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioequivalence of telithromycin administered orally as crushed tablets versus tablets swallowed whole.
    Lippert C; Gbenado S; Qiu C; Lavin B; Kovacs SJ
    J Clin Pharmacol; 2005 Sep; 45(9):1025-31. PubMed ID: 16100296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
    Shi J; Montay G; Chapel S; Hardy P; Barrett JS; Sack M; Marbury T; Swan SK; Vargas R; Leclerc V; Leroy B; Bhargava VO
    J Clin Pharmacol; 2004 Mar; 44(3):234-44. PubMed ID: 14973302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.
    Zhanel GG; Johanson C; Hisanaga T; Mendoza C; Laing N; Noreddin A; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1072-7. PubMed ID: 15531596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of food on the bioavailability of a new ketolide antibacterial, telithromycin.
    Bhargava V; Lenfant B; Perret C; Pascual MH; Sultan E; Montay G
    Scand J Infect Dis; 2002; 34(11):823-6. PubMed ID: 12578152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue penetration of cefpodoxime and cefixime in healthy subjects.
    Liu P; Müller M; Grant M; Obermann B; Derendorf H
    J Clin Pharmacol; 2005 May; 45(5):564-9. PubMed ID: 15831780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics of telithromycin and clarithromycin with Streptococcus pneumoniae and Staphylococcus aureus in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations.
    Alferova IV; Vostrov SN; Portnoy YA; Lubenko IY; Zinner SH; Firsov AA
    Int J Antimicrob Agents; 2005 Sep; 26(3):197-204. PubMed ID: 16122914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.
    Zeitlinger MA; Traunmüller F; Abrahim A; Müller MR; Erdogan Z; Müller M; Joukhadar C
    Int J Antimicrob Agents; 2007 Jan; 29(1):44-50. PubMed ID: 17189094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.